Skip to main content

West Pharmaceutical Services Value Stock - Dividend - Research Selection

West Pharmaceutical Services

ISIN: US9553061055, WKN: 864330

Market price date: 26.01.2022
Market price: 378,57 USD

West Pharmaceutical Services Fundamental data and company key figures of the share

Annual reports in USD
Key figures 12-04-2021
Cash flow
Net operating cash flow 472.000.000
Capital Expenditures -174.400.000
Free cash flow 297.600.000
Balance sheet
Total Equity 1.854.500.000
Liabilities & Shareholders equity 2.793.000.000
Income statement
Net income 346.000.000
Eps (diluted) 4,570
Diluted shares outstanding 75.800.000
Net sales/revenue

Fundamental ratios calculated on: 26-01-2022

Key figures 26-01-2022
Cash flow
P/C 60,76
P/FC 96,42
Balance sheet
Income statement
Div. Yield0,17%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization28.679.688.192,00 USD
CountryUnited States
IndicesS&P 500,MSCI World Index
SectorsHealth Care Supplies
Raw Data SourceUS GAAP in Millionen USD
Stock Split2013-09-27,2.000000/1.000000; 2004-09-30,2.000000/1.000000; 2004-09-29,2.000000/1.000000; 1987-06-02,2.000000/1.000000; 1982-05-06,2.000000/1.000000

Description of the company

West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,


Here's Why You Should Add Quest Diagnostics (DGX) Stock Now

Quest Diagnostics Incorporated DGX has been gaining as the company’s base business continues to improve sequentially, signifying industry-wide recovery. The company has raised its 2021 view based on higher-than-anticipated COVID-19 volumes, which buoys optimism. However,

West Pharmaceutical Services (WST) Dips More Than Broader Markets: What You Should Know

In the latest trading session, West Pharmaceutical Services (WST) closed at $378.36, marking a -1.35% move from the previous day.

Is it “Take Profit” Season for West Pharmaceutical (WST)?

Baron Funds, an asset management firm, published its “Baron Asset Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded here. Against this backdrop, Baron Asset Fund (the “Fund”) gained 5.04% (Institutional Shares), while the Russell Midcap Growth Index (the “Index”) gained 2.85%, and the S&P 500 Index gained 11.03%. The Fund’s […]

SmileDirectClub (SDC) Moves up on New Strategic Actions

SmileDirectClub's (SDC) new strategic actions are focused on supporting the key growth initiatives that will generate the highest return on investment.

West Announces Landmark Collaboration with Corning in Pharmaceutical Injectable Drug Delivery

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced an exclusive supply and technology agreement with Corning Incorporated (NYSE: GLW). The new collaboration includes a multimillion-dollar investment to expand Corning's Valor® Glass technology to enable advanced injectable drug packaging and delivery systems for the pharmaceutical industry with the goal of advancing patient safety and expanding access to life

Here's Why You Should Add LabCorp (LH) to Your Portfolio Now

Investors are optimistic about LabCorp (LH) backed by increased COVID-19 testing demand and development in high-growth areas.

West Pharmaceutical Services (WST) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference

The following slide deck was published by West Pharmaceutical Services, Inc.

What to watch today: Wall Street to open lower after Nasdaq's worst week since March 2020

U.S. stock futures indicated more losses to start the new week following the Nasdaq's and the S&P 500's worst weeks since March 2020.

Stocks making the biggest moves in the premarket: Kohl's, Snap, Peloton and more

The stocks making the biggest moves in premarket trading include Kohl's, Snap, Peloton, and more.

Earnings playbook: A complete guide to this week's reports, including the first of tech

Microsoft, Tesla and Apple will release quarterly results, alongside a handful of other tech firms. McDonald's and Boeing will also offer updates.